Prisca Obi

86c3552e-2ed3-438b-9af2-03e0bd1e3440

Virtus Therapeutics

2024

Affiliations

Yale University

Technologies

Therapeutic

Indication

Neurodegenerative Disease

Orphan Diseases

Executive Summary

View/Download

Virtus Therapeutics is pioneering a new class of activator compounds indicated to treat over twenty rare metabolic diseases, including pantothenate kinase-associated neurodegeneration (PKAN) and propionic acidemia.

Newsletter Signup

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Corporate Supporters

Program of

Initiated by